The Prognostic Value of 18F-FDG PET/CT Taken Immediately After Completion of Radiotherapy for Lung Cancer Treated with Concurrent Chemoradiotherapy: Comparison between PET/CT taken after completion of adjuvant Durvalumab - The Prognostic Value of PET/CT Taken Immediately After Completion lung Cancer Concurrent Chemoradiotherapy

Juntendo University Faculty of Medicine Urayasu Hospital0 sites36 target enrollmentMay 1, 2023

Conditionsnon small cell lung cancer

Overview

Phase: 未知
Intervention: Not specified
Conditions: non small cell lung cancer
Sponsor: Juntendo University Faculty of Medicine Urayasu Hospital
Enrollment: 36
Status: Not yet recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

May 1, 2023

End Date

December 31, 2026

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Juntendo University Faculty of Medicine Urayasu Hospital

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Patients with any component of small cell lung carcinomaPatients with evidence of a malignant pleural or pericardial effusion Prior invasive malignancy (except non\-melanomatous skin cancer) unless disease free for a minimum of 3 years Prior systemic chemotherapy for the studied cancer (prior chemotherapy for a different cancer is allowable) Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fieldsSevere, active co\-morbidity, defined as follows: Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months Transmural myocardial infarction within the last 6 months Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects Acquired immune deficiency syndrome based upon current Centres for Disease Control definition Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception Poorly controlled diabetes (defined as fasting glucose level \> 200 mg/dL) despite attempts to improve glucose control by fasting duration and adjustment of medications Patients with T4 disease with radiographic evidence of massive invasion of a large pulmonary artery and tumour causing significant narrowing and destruction of that artery